Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 3 × Cushing Syndrome × relacorilant × Clear all

Phase

Phase 3 2 Phase 2 2 Phase 1 2

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Hypertension 2 Diabetes Mellitus, Type 2 2 Cushing Syndrome 2 ACTH Syndrome, Ectopic 2 Pituitary ACTH Hypersecretion 1 Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Mifepristone 3 Corlux 3 relacorilant 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04308590 2025-09-04

GRADIENT

Corcept Therapeutics

Phase 3 Completed

137 enrolled 25 charts

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension

NCT03697109 2025-07-16

GRACE

Corcept Therapeutics

Phase 3 Completed

152 enrolled 28 charts

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Pituitary ACTH Hypersecretion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡